Meeting Banner
Abstract #4325

Investigating Pharmacological Modification of Cardiac Pyruvate Metabolism Using Hyperpolarized Magnetic Resonance

Lydia M. Le Page1, Michael S. Dodd1, Daniel R. Ball1, Vicky Ball1, Huw B. Jones2, Edvin Johansson3, Damian J. Tyler1

1University of Oxford, Oxford, United Kingdom; 2AstraZeneca, Alderley Park, Macclesfield, United Kingdom; 3AstraZeneca, Mlndal, Sweden

Increasing flux through the pyruvate dehydrogenase (PDH) enzyme has been considered as a potential treatment for type 2 diabetes, as it should lead to reduced blood glucose levels. In this study the ability to assess pharmacologically stimulated increases in PDH flux, both in vivo and ex vivo, has been demonstrated using hyperpolarized [1-13C]pyruvate in combination with magnetic resonance spectroscopy. The generic PDH kinase inhibitor, dichloroacetate, was seen to significantly increase PDH flux both in vivo and ex vivo, whilst the PDH kinase 2 specific inhibitor, AZD7545, did not result in changes to PDH flux in either situation.

Keywords

ability accompanied achieve achieved acid acquisition acquisitions action acute administered administration agreement alanine alkaline alteration amount amplitude animals application applied aqueous assessed ball balloon began bicarbonate biomedicine body buffer cardiac cardiovascular carried chronic cine compound computers concentration concentrations conditions containing continued control controls corrected daily days decrease delivery described dissolution dissolved doped dosed dosing either ejection enables enzyme every exchange fitted flux foundation fraction function heart hearts heated heather immediately in vivo infusion inhibition inhibitor inserted instruments investigate isolated kingdom lactate last lumen magnet male measured medicine metabolism metabolite mimic minute minutes mirrored mixture mode model modification offset output oxford package page partially particular peak peaks perfused perfusion period pharmacological physiological placed polarization polarizer polyethylene pressure previously process proposed protocol rats real reduction repeated sample saturated series situation situations sodium software solution spectra spectrum stabilization stroke structure subsequently successfully sufficient sugar supported suspension system systolic taken trace trans treated treatment ventricle vertical water